HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Herbert Yu Selected Research

Insulin-Like Growth Factor Binding Protein 3

7/2016Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.
11/2011Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women.
5/2009Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
3/2008Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
2/2008The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women.
1/2008Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women.
1/2008Insulin-like growth factor axis and oncogenic human papillomavirus natural history.
11/2007Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
1/2007Energy balance, insulin resistance biomarkers, and breast cancer risk.
7/2006Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Herbert Yu Research Topics

Disease

80Neoplasms (Cancer)
06/2022 - 05/2002
51Breast Neoplasms (Breast Cancer)
06/2022 - 05/2002
23Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 02/2006
17Obesity
01/2022 - 01/2008
17Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 09/2009
17Ovarian Epithelial Carcinoma
04/2016 - 02/2006
15Endometrial Neoplasms (Endometrial Cancer)
04/2021 - 04/2008
14Carcinogenesis
10/2021 - 06/2003
10Lung Neoplasms (Lung Cancer)
01/2021 - 02/2015
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2020 - 05/2007
10Disease Progression
02/2017 - 02/2006
7Insulin Resistance
01/2021 - 02/2004
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2008
4Adenocarcinoma
10/2021 - 01/2015
4Adenocarcinoma of Lung
08/2021 - 01/2013
4Neoplasm Metastasis (Metastasis)
11/2018 - 09/2009
4Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 04/2006
3Papillary Thyroid Cancer
01/2022 - 01/2017
3Fanconi Anemia (Fanconi's Anemia)
11/2021 - 01/2015
3Hemorrhage
01/2017 - 07/2014
3Residual Neoplasm
02/2012 - 12/2006
2Fibrosis (Cirrhosis)
01/2022 - 12/2021
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2016
2Inborn Genetic Diseases (Disease, Hereditary)
11/2021 - 01/2015
2Inflammation (Inflammations)
01/2021 - 12/2019
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2018 - 02/2008
2Liver Diseases (Liver Disease)
11/2018 - 02/2008
2Carcinoma (Carcinomatosis)
08/2018 - 09/2005
2Diabetes Mellitus
01/2017 - 07/2015

Drug/Important Bio-Agent (IBA)

26Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2007
24Insulin-Like Growth Factor I (IGF-1)IBA
01/2021 - 08/2002
19Insulin-Like PeptidesIBA
01/2021 - 08/2002
18Insulin-Like Growth Factor Binding Protein 3IBA
07/2016 - 08/2002
17Long Noncoding RNAIBA
06/2022 - 04/2015
16Proteins (Proteins, Gene)FDA Link
11/2021 - 05/2002
15Biological ProductsIBA
06/2022 - 01/2007
15Hormones (Hormone)IBA
06/2022 - 05/2003
15Estrogens (Estrogen)FDA Link
01/2021 - 05/2003
13Messenger RNA (mRNA)IBA
01/2021 - 10/2007
11MicroRNAs (MicroRNA)IBA
06/2022 - 11/2007
11Insulin-Like Growth Factor II (Somatomedin A)IBA
04/2016 - 08/2002
10Insulin (Novolin)FDA Link
01/2021 - 01/2008
10DNA (Deoxyribonucleic Acid)IBA
01/2014 - 11/2003
8Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021 - 05/2003
7Insulin-Like Growth Factor Binding ProteinsIBA
01/2021 - 08/2002
7PlatinumIBA
12/2020 - 09/2005
6ORALIT (ORS)IBA
01/2021 - 10/2003
6Estradiol (Delestrogen)FDA LinkGeneric
01/2021 - 05/2003
6CytokinesIBA
01/2021 - 02/2009
5RNA (Ribonucleic Acid)IBA
06/2022 - 02/2006
5Eukaryotic Initiation Factor-4EIBA
08/2006 - 05/2002
4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2008
4C-Reactive ProteinIBA
01/2021 - 02/2013
4Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 05/2002
4Vitamin DFDA LinkGeneric
07/2020 - 01/2015
4Estrogen ReceptorsIBA
01/2019 - 05/2002
4ABO Blood-Group SystemIBA
01/2017 - 04/2010
4Peptides (Polypeptides)IBA
04/2011 - 10/2007
4SteroidsIBA
11/2003 - 05/2003
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2022 - 07/2014
3LimoneneIBA
08/2021 - 01/2018
3Sex Hormone-Binding GlobulinIBA
01/2021 - 06/2003
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 02/2009
3Dietary Fats (Dietary Fat)IBA
01/2021 - 01/2020
3CholesterolIBA
01/2021 - 10/2008
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2020 - 04/2013
3Bile Acids and Salts (Bile Acids)IBA
01/2020 - 11/2018
3Genetic Markers (Genetic Marker)IBA
01/2020 - 08/2010
3Blood Group Antigens (Blood Groups)IBA
06/2013 - 09/2009
3Paclitaxel (Taxol)FDA LinkGeneric
08/2011 - 11/2007
3MitogensIBA
01/2009 - 10/2003
3Estrogen Receptor alphaIBA
01/2007 - 02/2006
2LipidsIBA
12/2021 - 01/2021
2Small Interfering RNA (siRNA)IBA
12/2021 - 02/2012
2Plant ExtractsIBA
08/2021 - 01/2018
2Protein Isoforms (Isoforms)IBA
01/2021 - 10/2016
2LDL CholesterolIBA
01/2021 - 10/2008
2oxidized low density lipoproteinIBA
01/2021 - 10/2008
2CateninsIBA
01/2021 - 11/2017
2LDL Lipoproteins (beta Lipoproteins)IBA
01/2021 - 10/2008
2HDL CholesterolIBA
01/2021 - 10/2008
28,11,14-Eicosatrienoic Acid (Dihomo-gamma-Linolenic Acid)IBA
12/2020 - 10/2015
2Particulate MatterIBA
10/2020 - 01/2018
2Epidermal Growth Factor (EGF)IBA
01/2020 - 06/2019
2Oral ContraceptivesIBA
01/2020 - 07/2013
2ErbB Receptors (EGF Receptor)IBA
06/2019 - 07/2016
2Untranslated RNA (Noncoding RNA)IBA
06/2019 - 12/2012
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2019 - 09/2018
2CarcinogensIBA
11/2018 - 01/2014
2Therapeutic UsesIBA
01/2018 - 02/2006
2LigandsIBA
07/2016 - 05/2012
2InterleukinsIBA
07/2016 - 02/2013
2LeptinIBA
07/2016 - 02/2009
2Nonesterified Fatty Acids (NEFA)IBA
01/2016 - 10/2015
2Fatty Acids (Saturated Fatty Acids)IBA
01/2016 - 04/2013

Therapy/Procedure

11Drug Therapy (Chemotherapy)
12/2020 - 09/2005
10Therapeutics
12/2021 - 06/2003
4Cytoreduction Surgical Procedures
04/2013 - 04/2007
3Radiotherapy
07/2011 - 08/2006
2Aftercare (After-Treatment)
01/2018 - 04/2009